Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Science 360 , 267268 (2018)
Other approaches Obesity is a widespread and heterogeneic disease that will require a variety of approaches, manufacturer Amgen has said, revealing that it is developing both oral and injectable approaches, comprising both incretin and non-incretin mechanisms
AC received grants from Astra Zeneca, Lilly, Novo-Nordisk
Se hai pagato tramite PayPal, Carta di credito, Satispay o Klarna riceverai una seconda email dai diversi provider a conferma del buon esito della transazione
US$ 27.55
US$ 20.32
US$ 22.77
US$ 28.80
US$ 29.14
